^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Gastric Cancer
    Drug:capecitabine (Thymidylate synthase inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    Source:
    European Medicines Agency
    Published date:
    04/20/2012
    Excerpt:
    Capecitabine Teva is indicated for first‑line treatment of advanced gastric cancer in combination with a platinum‑based regimen.
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Gastric Cancer: Principles of systemic therapy…Other recommended regimens…Fluoropyrimidine (Fluorouracil or capecitabine)